S K Field
Affiliation: University of Calgary
- Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPDMark A Giembycz
Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary, Alberta, Canada
Drug Des Devel Ther 4:147-58. 2010..Roflumilast is the first selective phosphodiesterase 4 inhibitor and will offer physicians another treatment option for patients with more severe COPD...
- Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of ExacerbationsStephen K Field
Division of Respiratory Medicine, University of Calgary, Calgary, Alberta, Canada
Clin Med Insights Circ Respir Pulm Med 5:57-70. 2011..Roflumilast, the first selective PDE4 inhibitor to be marketed, is a promising drug for the management of COPD patients with more severe disease...
- New treatment options for multidrug-resistant tuberculosisStephen K Field
Health Science Centre, 3330 Hospital Dr NW, Calgary, Alberta, Canada
Ther Adv Respir Dis 6:255-68. 2012..A number of novel drugs are undergoing clinical testing and will hopefully be available in the near future. These include the newer oxazolidinones, diarylquinolines, nitroimidazopyrans, ethenylenediamines, pyrroles, and benzothiazinones...
- Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthmaStephen K Field
Foothills Medical Centre and Tuberculosis Services, Calgary Health Region, Health Science Centre, 3330 Hospital Dr NW, Calgary, Alberta, T2N 4N1, Canada
Expert Opin Investig Drugs 17:811-8. 2008..Studies in asthma and chronic obstructive pulmonary disease (COPD) have demonstrated that it can improve lung function and reduce inflammation...
- Mycobacterium avium complex pulmonary disease in patients without HIV infectionStephen K Field
Division of Respiratory Medicine, University of Calgary Medical School, Calgary, AB, Canada
Chest 126:566-81. 2004..The prolonged treatment period, side effects, and possibly reinfection rather than relapse are responsible for the high failure rate...
- Steroids and/or cytotoxic agents should be used early in the management of patients with IPF - the con argumentStephen K Field
Division of Respirology, University of Calgary, Health Science Centre, Alberta
Can Respir J 11:212-3. 2004
- Effect of the management of patients with chronic cough by pulmonologists and certified respiratory educators on quality of life: a randomized trialStephen K Field
Calgary COPD and Asthma Program and Division of Respirology, Calgary Health Region, The University of Calgary, Calgary, AB, Canada
Chest 136:1021-8. 2009..This study was undertaken to see whether CREs could assist pulmonologists (MDs) in managing patients with chronic cough...
- Assessment and management of patients with chronic cough by Certified Respiratory Educators: a randomized controlled trialS K Field
Calgary Health Region, University of Calgary, Calgary, Canada
Can Respir J 16:49-54. 2009..In the present study, a prospective, randomized, controlled study was undertaken to determine whether Certified Respiratory Educators (CREs) could manage screened patients with chronic cough as effectively as respirologists...
- Gastroesophageal reflux and asthma: can the paradox be explained?S K Field
University of Calgary Medical School, Calgary, Canada
Can Respir J 7:167-76. 2000..The purpose of this paper is to review the evidence for a relationship between the two conditions...
- Gastroesophageal reflux and asthma: are they related?S K Field
Division of Respirology, University of Calgary Medical School and the Calgary Asthma Program, Alberta, Canada
J Asthma 36:631-44. 1999..The paradox of GER causing asthma symptoms but not changing pulmonary function may be explained by its increasing minute ventilation rather than triggering bronchospasm...
- The effects of antireflux surgery on asthmatics with gastroesophageal refluxS K Field
Department of Medicine, University of Calgary Medical School, Alberta, Canada
Chest 116:766-74. 1999..The purpose of this article is to review the available literature on the effects of antireflux surgery in asthma...
- Lung disease due to the more common nontuberculous mycobacteriaStephen K Field
Division of Respiratory Medicine, University of Calgary Medical School and Tuberculosis Services, Calgary Health Region, Calgary, AB, Canada
Chest 129:1653-72. 2006..The purpose of this article is to review the common presentations of NTM lung disease, the conditions associated with NTM lung disease, and the clinical features and treatment of the NTM that most commonly cause lung disease...
- A critical review of the studies of the effects of simulated or real gastroesophageal reflux on pulmonary function in asthmatic adultsS K Field
Foothills Medical Centre, Calgary, Alberta, Canada
Chest 115:848-56. 1999..To identify and critically review the published peer-reviewed, English-language studies of the effects of both spontaneous and simulated gastroesophageal reflux (GER) on pulmonary function in asthmatic adults...
- Asthma symptoms do not predict spirometryRobert L Cowie
University of Calgary, Calgary, Alberta
Can Respir J 14:339-42. 2007..Asthma is a disease characterized by variable airflow obstruction, but the measurement of airflow is often omitted in the process of diagnosis and management of the disease...
- Inhaled corticosteroid therapy does not control asthmaRobert L Cowie
Calgary COPD and Asthma Program, University of Calgary, Calgary, Canada
Can Respir J 11:555-8. 2004..Randomized clinical trials demonstrate efficacy and show that inhaled corticosteroid therapy can control asthma, but details concerning their effectiveness in achieving this goal in the community are lacking...
- A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosisAlain Tremblay
Alain Tremblay, MDUniversity of Calgary, Calgary, AB, Canada
Chest 136:340-6. 2009..The aim of this study was to compare the diagnostic yield of EBUS-guided TBNA to TBNA performed with a standard 19-gauge needle in patients with mediastinal adenopathy and a clinical suspicion of sarcoidosis...
- Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibilityH Yang
Tuberculosis Services, University of Calgary, Calgary, Alberta, Canada
Int J Tuberc Lung Dis 9:288-93. 2005..A centre managing all tuberculosis (TB) cases in the population of the Calgary region in Canada...
- Predicting emergency department utilization in adults with asthma: a cohort studyR L Cowie
Calgary Asthma Program, University of Calgary, Alberta, Canada
J Asthma 38:179-84. 2001..D. asthma treatment since entry to the cohort. This study suggests that special attention should be paid to subjects with asthma that interferes with their lifestyle and to those who have needed hospital admission for asthma...
- Underlying mechanisms of respiratory symptoms with esophageal acid when there is no evidence of airway responseS K Field
Department of Medicine, Division of Respiratory Medicine, University of Calgary Medical School, Calgary, Alberta, Canada T2N 2T9
Am J Med 111:37S-40S. 2001..Treating GER, either medically or surgically, may improve asthma symptoms by preventing GER-induced changes in minute ventilation...
- Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimineStephen K Field
Division of Respiratory Medicine University of Calgary Medical School and Calgary Health Region Tuberculosis Services, Calgary, AB, Canada
Chest 124:1482-6. 2003..Mycobacterium avium-intracellulare (MAC) causes progressive lung disease. Recommended treatment regimens include a macrolide and a rifamycin, but drug intolerance and relapse after treatment is completed often limit successful therapy...
- Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trialToni O Kiljander
Department of Pulmonary Diseases, Tampere University Hospital, FIN 33521, Tampere, Finland
Am J Respir Crit Care Med 173:1091-7. 2006..Gastroesophageal reflux disease (GERD) is common in patients with asthma, suggesting an interaction between the two conditions...
- Asthma and gastroesophageal reflux: another piece in the puzzle?Stephen K Field
Chest 121:1024-7. 2002